Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EERE | ISIN: US7595JP3044 | Ticker-Symbol: V6M1
Siehe auch RELIEF THERAPEUTICS HOLDING AG
München
03.07.25 | 08:00
2,320 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RELIEF THERAPEUTICS HOLDING AG ADR Chart 1 Jahr
5-Tage-Chart
RELIEF THERAPEUTICS HOLDING AG ADR 5-Tage-Chart

Aktuelle News zur RELIEF THERAPEUTICS HOLDING AG ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD0114.150Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Receives FDA Response to QIDP Request for RLF-TD011 20-Jun-2025 / 07:00 CET/CEST Release of an ad hoc announcement...
► Artikel lesen
12.06.Relief Therapeutics Holding SA: Relief Therapeutics Announces Results of Annual General Meeting337Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Results of Annual General Meeting 12.06.2025 / 11:00 CET/CEST Relief Therapeutics Announces...
► Artikel lesen
22.05.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD0114.804Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011 22-May-2025 / 07:00 CET/CEST Release of...
► Artikel lesen
15.05.Relief Therapeutics Holding SA: Relief Therapeutics Publishes 2025 Annual General Meeting Agenda494Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Publishes 2025 Annual General Meeting Agenda 15.05.2025 / 07:00 CET/CEST Relief Therapeutics Publishes...
► Artikel lesen
RELIEF THERAPEUTICS HOLDING AG ADR Aktie jetzt für 0€ handeln
10.04.Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B7
10.04.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update1.344Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update 10-Apr-2025 / 07:00 CET/CEST Release of an...
► Artikel lesen
07.03.Relief Therapeutics and Renexxion terminate merger talks4
06.03.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion6.330Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion 06-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement...
► Artikel lesen
11.02.Relief Therapeutics to get European patent for investigational drug RLF-TD01119
11.02.Relief Therapeutics Holding SA: Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011634Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 11.02.2025 / 07:00 CET/CEST Relief...
► Artikel lesen
22.01.Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US4.269Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US 22-Jan-2025 / 07:00 CET/CEST Release of...
► Artikel lesen
27.12.24Relief Therapeutics Holding SA: Relief Therapeutics Provides Update on Potential Transaction with Renexxion791Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Provides Update on Potential Transaction with Renexxion 27.12.2024 / 07:00 CET/CEST Relief Therapeutics...
► Artikel lesen
16.12.24Relief Therapeutics Holding SA: Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial541Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial 16.12.2024 / 07:00 CET/CEST Relief...
► Artikel lesen
13.12.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations10.610Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations 13-Dec-2024 / 23:00 CET/CEST Release...
► Artikel lesen
11.11.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa3.980Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa 11-Nov-2024 / 07:00...
► Artikel lesen
04.11.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger3.024Relief Therapeutics Holding SA / Key word(s): Merger Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger 04-Nov-2024 / 07:00 CET/CEST Release of an...
► Artikel lesen
29.10.24Relief Therapeutics Holding SA: Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE506Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE 29.10.2024 / 07:00 CET/CEST Relief...
► Artikel lesen
25.10.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents4.733Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents 25-Oct-2024 / 07:00 CET/CEST Release...
► Artikel lesen
21.10.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment3.165Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment 21-Oct-2024...
► Artikel lesen
08.10.24Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa3.514Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa 08-Oct-2024...
► Artikel lesen
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1